Phase III, Randomized, Double Blind, Parallel Groups, Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of the Lactobacillus Vaccine Gynevac, in the Treatment of Bacterial Vaginosis.
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2017
Price : $35 *
At a glance
- Drugs Lactobacillus vaccine (Primary)
- Indications Bacterial vaginosis
- Focus Registrational; Therapeutic Use
- Acronyms LATVAC
- Sponsors AmVac
- 31 Aug 2018 Biomarkers information updated
- 04 Jun 2016 Status changed from recruiting to discontinued.
- 27 May 2015 Completion of this trial is expected by the end of 2015, according to an AmVac media release.